Chimerix Stumbles Over Late Stage Results
Chimerix had a bad start to the week as it tumbled in early trading on Monday, following some late stage clinical trial results.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 224
The Top 4 Biopharma Movers of the Past Week
Over the past week, Zafgen and a few other biotech companies made impressive runs. These moves were the result of positive trial results and an FDA meeting.
AstraZeneca Gets European Approval for Heart Attack, Gout Treatments
AstraZeneca has announced that the European Commission granted marketing authorization for two of its treatments: Zurampic for gout and Brilique for heart attack patients.
Exagen Updates IPO Filing
Exagen Diagnostics has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Aerie Pharma Jumps on Positive Interim Safety Results
Aerie Pharmaceuticals was one of the more bullish health care stocks on Thursday morning, following the release of its interim safety results.
Zafgen Soars on Positive Phase 2 Results
Zafgen has announced positive efficacy results from its Phase 2b ZAF-203 clinical trial evaluating beloranib, a MetAP2 inhibitor, in the treatment of severe obesity complicated by type 2 diabetes.
Regulus Therapeutics Soars Over Interim HCV Results
Regulus Therapeutics has reported positive interim results from its Phase 2 study for the treatment of hepatitis C virus (HCV) infection.
Ocular Therapeutix Skyrockets on Positive FDA Meeting
Ocular Therapeutix led the bulls in early trading indications on Thursday, following a positive meeting with the FDA.
Express Scripts Meets Earnings and Guidance
Express Scripts Holding Co. (NASDAQ: ESRX) reported fourth quarter financial results after the markets closed on Tuesday. The company had $1.56 in earnings per share (EPS) on $26.18 billion in revenue compared to consensus…
Analysts Abandon Community Health Systems Bullish Case
Community Health Systems spooked investors badly enough that all hospital stocks were running in the red on Tuesday.
What to Expect From Express Scripts Earnings
Express Scripts is set to report its fourth-quarter financial results after the markets close on Tuesday.
Is This the Beginning of the End for Tonix Pharma?
In 2016 alone, this stock has taken a beating, and unless this company can turn itself around in the near future, it could be the end.
Pfizer Settles Medicaid Case for $785 Million
Pfizer has announced that it had settled outstanding claims for a total of more than $784 million related to calculated Medicaid rebates for the drug Protonix.
What to Expect From Baxalta Q4 Earnings
Baxalta is scheduled to report fourth-quarter and full-year results before markets open on Tuesday.
6 Biotech and Pharma Stocks Analysts Want You to Buy Now
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.